2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow ctDNA analysis: new trials by email Literature Review of ctDNA analysis trials Research Report on ctDNA analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAcTUS - Circulating Tumour DNA Guided Switch ctDNA analysis - Melanoma | Phase 2 | Unknown | The Christie NHS Foundation Trust | 21 | 2019-05-02 | 2023-08-25 |
| MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib TAGRISSO® 80mg (Osimertinib), Tumor biopsies, ctDNA analysis - Non-small Cell Lung Cancer | Phase 2 | Unknown | Nantes University Hospital | 150 | 2019-04-09 | 2024-02-28 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1)
Nantes University Hospital (1) · The Christie NHS Foundation Trust (1)
France (1) · United Kingdom (1)
Paul Lorigan (1)